Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
CDK2 Inhibition and Eradication of Aneuploid Cancers: Promise Meets Resistance.
Journal: Molecular cancer therapeutics
Published: February 17, 2026
Derivation and characterization of ubiquitin-specific protease 18 inhibitors.
Journal: JCI insight
Published: December 01, 2025
CDK2 inhibition produces a persistent population of polyploid cancer cells.
Journal: JCI insight
Published: December 06, 2024
Glycemic control in diabetic patients improved overall lung cancer survival across diverse populations.
Journal: JNCI cancer spectrum
Published: June 04, 2024
CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells.
Journal: Cancer biology & therapy
Published: November 30, 2023
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.
Journal: Scientific reports
Published: May 16, 2023
Real-World Studies Link Nonsteroidal Anti-inflammatory Drug Use to Improved Overall Lung Cancer Survival.
Journal: Cancer research communications
Published: July 14, 2022
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis.
Journal: Cancer biology & therapy
Published: April 07, 2022
TRIGGERING ANAPHASE CATASTROPHE TO COMBAT ANEUPLOID CANCERS.
Journal: Transactions of the American Clinical and Climatological Association
Published: July 18, 2020
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth.
Journal: Molecular cancer research : MCR
Published: June 30, 2020
Building an interdisciplinary pain medicine and palliative care program in Ethiopia.
Journal: Journal of global health
Published: April 08, 2020
Last Updated: 09/26/2026